SCHEMBL13669264

SCHEMBL13669264

CCOC(=O)c1ccc(-c2cn(S(=O)(=O)c3ccccc3)c3ncc(-c4ccc(OC)c(OC)c4)cc23)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 3/20 0.50
NPC1 O15118 2/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
PDGFRB P09619 1/20 0.46
PDGFRA P16234 1/20 0.46
MAPT P10636 2/20 0.46
TP53 P04637 1/20 0.46
GAK O14976 1/20 0.43
PDPK1 O15530 1/20 0.42
AAK1 Q2M2I8 5/20 0.42
CHEK1 O14757 1/20 0.41
CHEK2 O96017 1/20 0.41
MAOB P27338 1/20 0.41
F2RL3 Q96RI0 1/20 0.41
USP2 O75604 1/20 0.40
NTRK1 P04629 1/20 0.40
KIT P10721 1/20 0.40
PIK3CA P42336 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13669265 0.88 GAK (0.54) PTPN11GAKAAK1NTRK1KIT
SCHEMBL4336419 0.87 AAK1 (0.44) PTPN11NPC1RAB9ASMN1; SMN2PDGFRB
SCHEMBL13668879 0.84 KIT (0.50) PTPN11GAKAAK1NTRK1KIT
SCHEMBL13746240 0.84 PTPN11 (0.53) PTPN11PDGFRBPDGFRAPDPK1MAOB
SCHEMBL13746306 0.82 BRD4 (0.57) PTPN11NPC1RAB9ASMN1; SMN2PDGFRB
SCHEMBL13746286 0.81 AAK1 (0.50) PTPN11GAKAAK1NTRK1KIT
SCHEMBL13746238 0.81 PTPN11 (0.49) PTPN11NPC1RAB9ASMN1; SMN2PDGFRB
SCHEMBL15607500 0.78 AAK1 (0.52) MAPTGAKAAK1NTRK1KIT
SCHEMBL4337406 0.78 BRD4 (0.59) MAPTGAKAAK1NTRK1KIT
SCHEMBL1516618 0.78 PTPN11 (0.48) PTPN11NPC1SMN1; SMN2PDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605168-B2 Phosphodiesterase 4; asthma, chronic obstructive pulmonary disease, Alzheimer's disease, diffuse large-cell B cell lymphoma, and chronic lymphocytic leukemia; 8-[3-(3,4-dimethoxy-phenyl)-pyrrolo[2,3-b]pyridine-1-sulfonyl]-quinoline PLEXXIKON, INC. (US) 2009-10-20 US disclosed